Ms Kim Appleton

  • Project Manager (MRC/CSO Social & Public Health Sciences Unit)

Publications

List by: Type | Date

Jump to: 2018 | 2017 | 2014 | 2011 | 2008 | 2007 | 2005
Number of items: 9.

2018

Jahoda, A. et al. (2018) Behavioural activation versus guided self-help for depression in adults with learning disabilities: the BeatIt RCT. Health Technology Assessment, 22(53), (doi:10.3310/hta22530) (PMID:30265239)

2017

Jahoda, A. et al. (2017) Comparison of behavioural activation with guided self-help for treatment of depression in adults with intellectual disabilities: a randomised controlled trial. Lancet Psychiatry, 4(12), pp. 909-919. (doi:10.1016/S2215-0366(17)30426-1) (PMID:29153873) (PMCID:PMC5714593)

2014

Glasspool, R.M. et al. (2014) A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer. British Journal of Cancer, 110(8), pp. 1923-1929. (doi:10.1038/bjc.2014.116)

2011

Doyle, B., O'Riain, C. and Appleton, K. (2011) Pyrosequencing of DNA extracted from formalin-fixed paraffin-embedded tissue. In: Al-Mulla, F. (ed.) Formalin-Fixed Paraffin-Embedded Tissues. Series: Methods in molecular biology (724). Springer, pp. 181-190. (doi:10.1007/978-1-61779-055-3_12)

2008

Appleton, K. , Setanoians, A., McCormick, C., Ullah, R., Brown, R. and Evans, J. (2008) Detection of methylation at hMLH1 by fluorescent methylation specific PCR (F-MSP) in a Phase II trial of the demethylating agent decitabine in combination with carboplatin. In: Beatson West of Scotland Cancer Centre 2nd International Symposium, Glasgow, UK, June 2008,

2007

Appleton, K. et al. (2007) Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors. Journal of Clinical Oncology, 25(29), pp. 4603-4609. (doi:10.1200/JCO.2007.10.8688)

Appleton, K. , Mackay, H., Judson, I., Plumb, J. and McCormick, C. (2007) The pharmodynamic effects of decitabine in combination with carboplatin: results from a phase 1 clinical trial. In: Beatson West of Scotland Cancer Centre 1st International Symposium, Glasgow, Scotland, June 2007,

Ullah, R., Appleton, K. , Blackie, R., McCormick, C., Setanoians, A. and Evans, J. (2007) Implementation of Good Clinical Laboratory Practice (GCLP) in Translational Research. In: Beatson West of Scotland Cancer Centre 1st International Symposium, Glasgow, Scotland, June, 2007,

2005

Brown, R. et al. (2005) Pharmacodynamic effects in patients treated with 6 hour infusion of the demethylating agent 5-aza-2 ' deoxycytidine (decitabine). In: AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics, Philadelphia, Pennsylvania, November 14-18, 2005, 9071S-9072S.

This list was generated on Sat Feb 16 16:06:24 2019 GMT.
Number of items: 9.

Articles

Jahoda, A. et al. (2018) Behavioural activation versus guided self-help for depression in adults with learning disabilities: the BeatIt RCT. Health Technology Assessment, 22(53), (doi:10.3310/hta22530) (PMID:30265239)

Jahoda, A. et al. (2017) Comparison of behavioural activation with guided self-help for treatment of depression in adults with intellectual disabilities: a randomised controlled trial. Lancet Psychiatry, 4(12), pp. 909-919. (doi:10.1016/S2215-0366(17)30426-1) (PMID:29153873) (PMCID:PMC5714593)

Glasspool, R.M. et al. (2014) A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer. British Journal of Cancer, 110(8), pp. 1923-1929. (doi:10.1038/bjc.2014.116)

Appleton, K. et al. (2007) Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors. Journal of Clinical Oncology, 25(29), pp. 4603-4609. (doi:10.1200/JCO.2007.10.8688)

Book Sections

Doyle, B., O'Riain, C. and Appleton, K. (2011) Pyrosequencing of DNA extracted from formalin-fixed paraffin-embedded tissue. In: Al-Mulla, F. (ed.) Formalin-Fixed Paraffin-Embedded Tissues. Series: Methods in molecular biology (724). Springer, pp. 181-190. (doi:10.1007/978-1-61779-055-3_12)

Conference Proceedings

Appleton, K. , Setanoians, A., McCormick, C., Ullah, R., Brown, R. and Evans, J. (2008) Detection of methylation at hMLH1 by fluorescent methylation specific PCR (F-MSP) in a Phase II trial of the demethylating agent decitabine in combination with carboplatin. In: Beatson West of Scotland Cancer Centre 2nd International Symposium, Glasgow, UK, June 2008,

Appleton, K. , Mackay, H., Judson, I., Plumb, J. and McCormick, C. (2007) The pharmodynamic effects of decitabine in combination with carboplatin: results from a phase 1 clinical trial. In: Beatson West of Scotland Cancer Centre 1st International Symposium, Glasgow, Scotland, June 2007,

Ullah, R., Appleton, K. , Blackie, R., McCormick, C., Setanoians, A. and Evans, J. (2007) Implementation of Good Clinical Laboratory Practice (GCLP) in Translational Research. In: Beatson West of Scotland Cancer Centre 1st International Symposium, Glasgow, Scotland, June, 2007,

Brown, R. et al. (2005) Pharmacodynamic effects in patients treated with 6 hour infusion of the demethylating agent 5-aza-2 ' deoxycytidine (decitabine). In: AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics, Philadelphia, Pennsylvania, November 14-18, 2005, 9071S-9072S.

This list was generated on Sat Feb 16 16:06:24 2019 GMT.